Oral dimethyl fumarate induces changes within the peripheral neutrophil compartment of patients with psoriasis that are linked with skin improvement.

Morrison, P J; Suhrkamp, I; Gerdes, S; Mrowietz, U

Morrison, P J; Suhrkamp, I; Gerdes, S; Mrowietz, U.

Afiliação

Morrison PJ; Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, 24105, Germany.
Suhrkamp I; Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, 24105, Germany.
Gerdes S; Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, 24105, Germany.
Mrowietz U; Psoriasis Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, 24105, Germany.

Br J Dermatol ; 185(3): 605-615, 2021 09.

Article em En | MEDLINE | ID: mdl-33657656

Assuntos

Fármacos Dermatológicos; Esclerose Múltipla; Psoríase; Fumarato de Dimetilo; Humanos; Neutrófilos; Psoríase/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Esclerose Múltipla Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google